trending Market Intelligence /marketintelligence/en/news-insights/trending/x-fXjTjpddjZKVoSLVVXVA2 content esgSubNav
In This List

Allergan COO to leave company

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Allergan COO to leave company

Allergan plc executive vice president and COO Rob Stewart is leaving the company to become the president of Amneal Pharmaceuticals LLC on Jan. 25, 2018.

Wayne Swanton has been appointed Allergan's executive vice president of global operations following Stewart's notification that he is leaving.

Stewart will become the president, CEO and board member of Amneal Pharmaceuticals once it combines with Impax Laboratories Inc.

The combined company will be known as Amneal Pharmaceuticals, and will see Impax President and CEO Paul Bisaro become its executive chairman.

Meanwhile, Amneal's co-CEOs and co-founders, Chirag Patel and Chintu Patel, will serve as co-chairmen of the combined company's board.